1. Spain Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Clinica Baviera SA

Clinica Baviera SA

53.80
EUR
0.00
(0.00%)
2.92EPS
20.09P/E
923.14MMarket Cap
Nov 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.91
5.07
5.25
5.62
6.12
6.7
7.63
7.52
10.59
12.17
13.8
16.41
18.85
19.78
Basic EPS, GAAP
0.3
0.25
0.3
0.49
0.6
0.73
0.78
0.86
1.68
1.81
2.21
2.51
2.63
2.87
Free Cash Flow per Basic Share
0.39
0.34
0.31
0.42
0.42
0.45
0.99
1.45
2.23
2.41
2.16
2.25
2.92
2.89
Dividend per Share
0.1
0.56
0.22
0.63
0.22
0.49
0.59
- -
1.06
1.05
0.83
1.62
1.65
0.03
Book Value per Share
1.53
1.22
1.29
1.13
1.51
1.75
1.88
2.73
3.35
4.13
5.58
6.06
6.87
6.96
Tangible Book Value per Share
0.74
0.43
0.49
0.33
0.65
0.89
0.96
1.8
2.39
3.21
4.52
3.7
4.36
4.39
Basic Weighted Avg Shares
16
16
16
16
16
16
16
16
16
16
16
16
16
16
Sales/Revenue/Turnover
80
83
86
92
100
109
124
123
173
198
225
263
302
317
Operating Margin (%)
9.85
6.82
7.64
12.67
13.64
15.54
14.79
16.73
22.85
21.22
22.25
21.19
20.09
20.37
Depreciation Expense
5
5
5
5
4
5
13
14
14
15
17
21
24
26
Net Income, GAAP
5
4
5
8
10
12
13
14
27
30
36
40
42
46
Effective Tax Rate (%)
30.63
23.27
27.24
29.96
26.45
29.15
27.47
29.99
28.2
25.89
26.02
26.53
28.57
27.75
Profit Margin (%)
6.11
4.91
5.71
8.64
9.78
10.82
10.29
11.37
15.86
14.87
15.99
15.31
13.94
14.5
Working Capital
2
1
1
-2
-3
-6
-17
-1
2
4
12
-3
-2
-4
LT Debt
6
12
10
11
9
8
42
42
40
38
37
52
57
7
Total Equity
25
20
21
19
25
29
31
45
55
68
92
98
111
112
Return on Invested Capital (%)
13.09
11.71
13.18
22.78
26.14
28.48
20.31
15.04
26.53
26.72
27.8
26.09
24.19
39.07
Return on Capital (%)
14.16
12.24
14.47
22.85
26.13
28.91
20.72
15.34
26.3
26.16
27.84
26.64
24.94
41.29
Return on Common Equity (%)
21.11
18.08
23.82
40
45.35
44.57
43.31
37.14
55.28
48.41
45.43
42.79
40.66
45.47

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
13
- -
3
LT Borrowings
7
7
7
LT Finance Leases
50
61
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
778
782
923

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
59
74
63
Cash, Cash Equivalents & STI
50
65
52
Accounts Receivable, Net
5
9
5
Inventories
3
- -
4
Total Current Liabilities
61
60
67
Payables & Accruals
- -
- -
- -
ST Debt
13
- -
3
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.07%
20.23%
12.8%
Free Cash Flow
29.08%
16.75%
30.08%
Net Income, GAAP
26.63%
28.5%
4.62%
Sales/Revenue/Turnover
13.87%
20.15%
14.9%
Total Cash Common Dividend
- -
- -
1.99%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
66
65
57
74
263
2025
80
75
65
82
302
2026
87
83
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.76
0.69
0.28
0.76
2.51
2025
0.8
0.59
0.37
0.86
2.63
2026
0.92
0.72
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
0.01
1.62
2025
0.03
1.59
0.01
0.01
1.65
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Luis Grávalos Soria
Full Time Employees
1,910
Sector
Health services
Industry
Hospital/Nursing management
Address
Paseo de la Castellana 20 Madrid MA Spain 28046
IPO Date
Apr 4, 2007
Website
clinicabaviera.com
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Clínica Baviera, S.A. (CBAV.MC) operates as a leading European provider of ophthalmology services and premium intraocular lenses. The company offers a comprehensive range of eye care solutions, including refractive surgery such as LASIK, PRK, and SMILE procedures; cataract surgery with implantation of monofocal, multifocal, and toric intraocular lenses under its own PhysIOL brand; presbyopia and keratoconus treatments via corneal cross-linking and intracorneal rings; diagnostic services encompassing optical coherence tomography, corneal topography, and wavefront aberrometry; and premium intraocular lens manufacturing through its PhysIOL subsidiary, featuring aspheric, diffractive, and light-adjustable models. It serves patients seeking vision correction across consumer and professional segments in the healthcare industry, with operations spanning Spain, Italy, Germany, the Netherlands, Portugal, Switzerland, and Austria. Founded in 1987 and headquartered in Alicante, Spain, Clínica Baviera maintains a network of over 40 clinics and surgical centers focused on advanced ophthalmologic care. The company emphasizes innovation in refractive and cataract technologies, targeting both private-pay individuals and insured patients in Western Europe. In recent developments, Clínica Baviera expanded its premium intraocular lens portfolio through PhysIOL's launch of next-generation diffractive lenses in 2024, enhancing multifocal vision outcomes; formed a strategic distribution alliance with key European optics firms for broader market penetration; and completed the acquisition of two regional ophthalmology clinics in Italy during 2025 to strengthen its Mediterranean presence. These moves follow a 2023 reorganization that streamlined its international operations for greater efficiency amid rising demand for outpatient eye procedures.